ACLS vs ASML

ACLS exhibits strong financial health per the Piotroski F-Score of 7/9, indicating robust operational efficiency and stability, though the absence of an Altman Z-Score raises caution regarding default risk. The stock trades at a premium to its Graham Number ($53.67) and intrinsic value ($26.60), suggesting valuation is driven by growth expectations rather than conservative fundamentals. Despite a recent earnings decline (YoY EPS -28.3%), the company has consistently beaten estimates over the past four quarters with an average surprise of 37.69%, signaling strong earnings quality. However, negative revenue and earnings growth, combined with bearish insider activity, introduce near-term caution. The 1-year return of +43% reflects strong momentum, but recent 6-month and 1-month declines suggest profit-taking or sector rotation.

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.